Unibest

Pharmaceutical intermediates

Valbenazine Tosylate (NBI-98854) Intermediates

2 pharmaceutical intermediates for Valbenazine Tosylate (NBI-98854). Indication: Huntington's chorea; Tardive dyskinesia.

提交项目All intermediates

About Valbenazine Tosylate (NBI-98854)

Originator
Neurocrine Biosciences Inc
Indication
Huntington's chorea; Tardive dyskinesia
Approved Date
04/11/2017
DS/DP
11/08/2027

Available intermediates

2 intermediates currently listed for Valbenazine Tosylate (NBI-98854). Request specifications, documentation or a quotation for any item below.

Valbenazine Tosylate (NBI-98854) intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
2H-Benzo[a]quinolizin-2-one, 1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-, (3R,11bR)-1026016-83-0//
[2R-(2a,3b,11bb)]-1,3,4,6,7,11b-Hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-2H-benzo[a]quinolizin-2-ol85081-18-1//

Other programs under V

Varenicline TartrateVelpatasvirVenetoclaxVericiguatVibegronVilazodone HydrochlorideVONOPRAZAN FUMARATEVoxelotor

Building toward Valbenazine Tosylate (NBI-98854)?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

提交项目 联系团队

我们能如何帮助您？

获取最新活动与法规动态洞察

直接发送到您的邮箱

在此获取行业洞察与 Unibest 动态

联系我们 →